NF-κB Activation Boosts Radioresistance in GSDME-Low ESCC
Recent research has unveiled critical insights into the interplay between pathophysiology and treatment resistance in esophageal squamous cell carcinoma (ESCC), ...
Recent research has unveiled critical insights into the interplay between pathophysiology and treatment resistance in esophageal squamous cell carcinoma (ESCC), ...
In a groundbreaking development in cancer immunotherapy, researchers have unveiled a novel strategy to disentangle the powerful antitumor effects of ...
Recent advancements in the oncology field have unveiled a complex relationship between cancer-associated fibroblasts (CAFs) and pancreatic cancer cells, revealing ...
In recent years, the landscape of cancer treatment has undergone a dramatic evolution, driven by significant advancements in immunotherapy, precision ...
In recent years, the convergence of nanotechnology and medical science has opened new avenues for targeted therapy, leading to innovative ...
Recent breakthroughs in oncology are reshaping how we approach the challenge of halting cancer progression, with a novel emphasis on ...
In the struggle against cancer, scientists are continually unraveling the complex interactions that govern tumor behavior and therapy response. Among ...
A groundbreaking study published in the latest volume of Oncotarget reveals a promising therapeutic synergy between aramchol, an emerging SCD1 ...
A groundbreaking new study from researchers at Keck Medicine of USC illuminates a promising therapeutic avenue for glioblastoma, one of ...
In the evolving battlefield of cancer immunotherapy, a groundbreaking discovery is shedding light on why a majority of patients fail ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine